Back to TRDA

GOLDMAN SACHS GROUP INC → TRDA

GOLDMAN SACHS GROUP INC TRDA Position History

Entrada Therapeutics, Inc. • Healthcare

Quarters held
14
Latest value
$508K
Q3 2026
Peak value
$1.6M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$215K
Q2 2025$350K
Q3 2025$807K
Q3 2025$483K
Q4 2025$914K
Q4 2025$1.2M
Q4 2025$1.2M
Q4 2025$914K
Q1 2026$1.6M
Q1 2026$1.1M
Q2 2026$1M
Q2 2026$283K
Q3 2026$1.4M
Q3 2026$508K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$508K80.1K——
Q3 2026$1.4M218.1K——
Q2 2026$283K38.4K——
Q2 2026$1M138.9K——
Q1 2026$1.1M85.7K——
Q1 2026$1.6M127.0K——
Q4 2025$914K88.9K——
Q4 2025$1.2M116.3K——
Q4 2025$1.2M116.3K——
Q4 2025$914K88.9K——
Q3 2025$483K83.2K——
Q3 2025$807K139.1K——
Q2 2025$350K52.1K——
Q2 2025$215K32.0K——

Other funds holding TRDA

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B